Allogene Therapeutics
ALLO
ALLO
155 hedge funds and large institutions have $460M invested in Allogene Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 60 increasing their positions, 47 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 173 → 155 (-18)
11% less call options, than puts
Call options by funds: $354K | Put options by funds: $399K
63% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 27
Holders
155
Holding in Top 10
3
Calls
$354K
Puts
$399K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$7.26M | |
| 3 | +$3.76M | |
| 4 |
BlackRock
New York
|
+$3.72M |
| 5 |
Goldman Sachs
New York
|
+$1.77M |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$3.45M | |
| 3 | -$3.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.67M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.05M |